ABCL: AbCellera Biologics Inc. Stock

by  •  • Comments Off on ABCL: AbCellera Biologics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 712.19
Enterprise Value ($M) 555.87
Book Value ($M) 1,056.08
Book Value / Share 3.54
Price / Book 0.67
NCAV ($M) 446.90
NCAV / Share 1.50
Price / NCAV 1.59

Profitability (mra)
Return on Invested Capital (ROIC) -0.15
Return on Assets (ROA) -0.11
Return on Equity (ROE) -0.14

Liquidity (mrq)
Quick Ratio 9.81
Current Ratio 9.81

Balance Sheet (mrq) ($M)
Current Assets 751.37
Assets 1,360.55
Liabilities 304.47
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 28.83
Operating Income -282.77
Net Income -162.86

Cash Flow Statement (mra) ($M)
Cash From Operations -108.56
Cash from Investing 121.41
Cash from Financing 12.77

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Baker Bros. Advisors Lp 9.30 20.15
10-09 13G/A Baillie Gifford & Co 4.40 -46.37

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 790,632 2,891,156 27.35
2025-04-16 1,567,844 4,325,836 36.24
2025-04-15 2,518,134 5,723,044 44.00
2025-04-14 1,342,554 4,071,761 32.97

(click for more detail)

Similar Companies
ABOS – Acumen Pharmaceuticals, Inc. ABUS – Arbutus Biopharma Corporation


Financial data and stock pages provided by
Fintel.io

Finpedia: AbCellera Biologics